---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-052598"
form_type: "8-K"
ticker: "ARDT"
cik: "0001756655"
company_name: "Ardent Health, Inc."
filed_at: "2026-08-04T20:16:33+00:00"
generated_at: "2026-08-04T20:18:53.465844+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ardent Health Q2 net income $17M ($0.12 EPS) vs $73M; Adjusted EBITDA $115M, down 32% YoY

## Summary
- Net income attributable to Ardent Health $17M ($0.12 diluted EPS) vs $73M ($0.52) in Q2 2025; revenue $1.62B, down 1.4% YoY.
- Adjusted EBITDA $115M, down 32.3% YoY; operating cash flow $197M, up 67% YoY.
- Reaffirmed FY2026 guidance: revenue $6.4B-$6.7B, Adjusted EBITDA $485M-$535M; lowered net income guidance to $110M-$163M.
- IMPACT program savings target raised to at least $70M in 2026 (from $55M); repurchased 1.4M shares for $13M in Q2.
- Admissions down 1.0%, surgeries down 2.9% YoY; adjusted admissions up 2.5%.

## SEC filing metadata
- accession: 0001628280-26-052598
- form_type: 8-K
- ticker: ARDT
- cik: 0001756655
- company_name: Ardent Health, Inc.
- filed_at: 2026-08-04T20:16:33+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1756655/000162828026052598/0001628280-26-052598-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1756655/000162828026052598/ardt-20260804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-052598
- JSON: https://secwatch.observer/filing/0001628280-26-052598.json
- Plain text: https://secwatch.observer/filing/0001628280-26-052598.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.